Published in PLoS One on September 23, 2015
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature (2016) 1.38
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus. PLoS Negl Trop Dis (2016) 0.87
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep (2017) 0.80
Origin and Evolution of RNA-Dependent RNA Polymerase. Front Genet (2017) 0.75
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr (2004) 31.52
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science (1998) 11.23
Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature (1998) 10.49
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ (1978) 9.23
The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc (2015) 8.53
Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. Nucleic Acids Res (1984) 8.36
PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res (2008) 7.16
Origins and evolutionary relationships of retroviruses. Q Rev Biol (1989) 6.82
CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res (2012) 6.39
Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol (1993) 6.36
Function and structure relationships in DNA polymerases. Annu Rev Biochem (1994) 5.66
RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A (2001) 5.21
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
DNA polymerases: structural diversity and common mechanisms. J Biol Chem (1999) 5.00
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science (1995) 4.98
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol (1991) 4.72
Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol (1997) 4.71
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
Expression of animal virus genomes. Bacteriol Rev (1971) 4.33
A mechanism for initiating RNA-dependent RNA polymerization. Nature (2001) 3.99
Striking similarities in amino acid sequence among nonstructural proteins encoded by RNA viruses that have dissimilar genomic organization. Proc Natl Acad Sci U S A (1984) 3.95
Structure of the RNA-dependent RNA polymerase of poliovirus. Structure (1997) 3.88
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol (1990) 3.72
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol (2008) 2.88
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell (2002) 2.80
Choosing the right sugar: how polymerases select a nucleotide substrate. Proc Natl Acad Sci U S A (1997) 2.79
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother (1987) 2.60
Structural similarity of DNA-binding domains of bacteriophage repressors and the globin core. Curr Biol (1993) 2.53
Structural basis of high-fidelity DNA synthesis by yeast DNA polymerase delta. Nat Struct Mol Biol (2009) 2.44
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. Antimicrob Agents Chemother (2007) 2.21
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res (2014) 2.21
A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol (2005) 2.14
Nucleic acid polymerases use a general acid for nucleotidyl transfer. Nat Struct Mol Biol (2009) 2.13
The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc Natl Acad Sci U S A (2004) 2.05
Structure of influenza A polymerase bound to the viral RNA promoter. Nature (2014) 1.95
Structure-function relationships among RNA-dependent RNA polymerases. Curr Top Microbiol Immunol (2008) 1.90
Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy. Cell (2015) 1.86
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res (2013) 1.79
Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol (2007) 1.78
A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res (2003) 1.77
Poliovirus RNA-dependent RNA polymerase (3Dpol): kinetic, thermodynamic, and structural analysis of ribonucleotide selection. Biochemistry (2004) 1.76
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75
Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog (2010) 1.73
Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature (2014) 1.73
Motif D of viral RNA-dependent RNA polymerases determines efficiency and fidelity of nucleotide addition. Structure (2012) 1.71
Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter. Cell (2015) 1.71
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med (2013) 1.66
Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis (1989) 1.65
Characterization of the L gene and 5' trailer region of Ebola virus. J Gen Virol (1999) 1.63
Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J Virol (2003) 1.60
Unlocking the sugar "steric gate" of DNA polymerases. Biochemistry (2011) 1.56
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Virus Res (2008) 1.48
The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage. J Mol Biol (2002) 1.48
Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrob Agents Chemother (2005) 1.48
Potential and emerging treatment options for Ebola virus disease. Ann Pharmacother (2014) 1.48
A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44
Polymerase activity of in vitro mutated rabies virus L protein. Virology (1995) 1.44
Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrob Agents Chemother (2008) 1.40
Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res (2008) 1.38
Sequential structures provide insights into the fidelity of RNA replication. Proc Natl Acad Sci U S A (2007) 1.37
Point mutations which drastically affect the polymerization activity of encephalomyocarditis virus RNA-dependent RNA polymerase correspond to the active site of Escherichia coli DNA polymerase I. J Biol Chem (1992) 1.30
Comparative analysis of protein structure alignments. BMC Struct Biol (2007) 1.28
E. coli DNA polymerase I as a reverse transcriptase. EMBO J (1993) 1.22
The structure of a birnavirus polymerase reveals a distinct active site topology. Proc Natl Acad Sci U S A (2007) 1.22
Favipiravir (T-705) inhibits in vitro norovirus replication. Biochem Biophys Res Commun (2012) 1.20
Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer. J Virol (2005) 1.17
Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell (2010) 1.15
Negative-strand RNA viruses: the plant-infecting counterparts. Virus Res (2011) 1.14
Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase. EMBO J (2012) 1.12
First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother (2012) 1.12
On the early evolution of RNA polymerase. J Mol Evol (1988) 1.10
Filovirus replication and transcription. Future Virol (2007) 1.09
Structure and function of RNA replication. Annu Rev Microbiol (2006) 1.08
Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase? Curr Opin Struct Biol (2009) 1.07
Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Res (2009) 1.06
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Res (2009) 1.04
Analysis of the mutations in the active site of the RNA-dependent RNA polymerase of human parainfluenza virus type 3 (HPIV3). Gene Expr (2002) 1.02
On the early emergence of reverse transcription: theoretical basis and experimental evidence. J Mol Evol (1992) 0.99
Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion. Proc Natl Acad Sci U S A (2010) 0.97
Role of motif B loop in allosteric regulation of RNA-dependent RNA polymerization activity. J Mol Biol (2013) 0.95
Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase. J Virol (2000) 0.94
Evolution of tertiary structure of viral RNA dependent polymerases. PLoS One (2014) 0.93
Detecting the emergence of novel, zoonotic viruses pathogenic to humans. Cell Mol Life Sci (2014) 0.92
Effect of single amino acid mutations in the conserved GDNQ motif of L protein of Rinderpest virus on RNA synthesis in vitro and in vivo. Virus Res (2004) 0.92
Highly pathogenic RNA viral infections: challenges for antiviral research. Antiviral Res (2008) 0.89
Adenovirus: current epidemiology and emerging approaches to prevention and treatment. Curr Infect Dis Rep (2014) 0.86
A cutting-edge view on the current state of antiviral drug development. Med Res Rev (2013) 0.86
A Structural Overview of RNA-Dependent RNA Polymerases from the Flaviviridae Family. Int J Mol Sci (2015) 0.86
Hepatitis C RNA-dependent RNA polymerase inhibitors: a review of structure-activity and resistance relationships; different scaffolds and mutations. Bioorg Med Chem (2012) 0.85
Crystal structures of murine norovirus-1 RNA-dependent RNA polymerase in complex with 2-thiouridine or ribavirin. Virology (2012) 0.84
Highly similar structural frames link the template tunnel and NTP entry tunnel to the exterior surface in RNA-dependent RNA polymerases. Nucleic Acids Res (2012) 0.81